ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
130,400
+1,700 (1.32%)
At close: Mar 20, 2026
Market Cap2.04T
Revenue (ttm)20.33B +54.6%
Net Income-7.33B
EPS-669.94
Shares Out15.62M
PE Ration/a
Forward PE238.83
Dividendn/a
Ex-Dividend Daten/a
Volume773,650
Average Volume614,514
Open130,000
Previous Close128,700
Day's Range122,000 - 135,600
52-Week Range13,740 - 135,600
Betan/a
RSI76.35
Earnings DateMar 27, 2026

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

Financial Statements